Phage Futures 2024

5th Annual Event

Accelerating the translation of bacteriophages from bench to clinically & commercially viable products

VIEW THE AGENDA
Boston, USA
19 November, 2024

“Phage Futures endeavours every year to put together an extraordinary program encompassing the most recent advances in the clinical application of bacteriophages and commercially viable non-traditional therapeutics.”

Phagelux

Welcome To Phage Futures 2024

This is your leading phage therapy networking platform to address the critical challenges in regulation, manufacturing, investment, R&D, and commercial landscapes

The all-new agenda will focus on:

  • Addressing the progress and need for phage therapeutic regulatory guidance including participation from the MHRA discussing standardization developments.

  • Overcoming hurdles in phage manufacturing, developing solutions to endotoxicity and quality whilst platforming use cases of innovative technology e.g. artificial intelligence.

  • Unparalleled opportunities to network with strategic partners, pharmaceutical companies, funders and investors to progress your business development and tackle commercial barriers.

  • Major preclinical/clinical breakthroughs across human health, animal health, aquaculture, aquaculture, nutrition, and cosmetic industries.

 DOWNLOAD THE AGENDA

Trailblazing Speakers

 

Mimi Yen

CEO & Co-Founder
PhagePro Inc.

Dr. Yen is a 2018 MIT Technology Review Innovator Under 35 and a microbiologist with a global health and program management background. Since co-founding PhagePro, Dr. Yen has received numerous awards and won several startup competitions recognizing her innovative leadership in global health, such as the ASTMH Innovations Pitch Competition and LaunchBio's The Big Pitch. She has been selected for several fellowships, including the MassNextGen Fellowship for women-led early-stage life science businesses, The Capital Network Female Founder Fellowship, and the Henri Termeer Legacy Program.

Mimi Yen

CEO & Co-Founder
PhagePro Inc.

Mimi Yen

CEO & Co-Founder
PhagePro Inc.

Dr. Yen is a 2018 MIT Technology Review Innovator Under 35 and a microbiologist with a global health and program management background. Since co-founding PhagePro, Dr. Yen has received numerous awards and won several startup competitions recognizing her innovative leadership in global health, such as the ASTMH Innovations Pitch Competition and LaunchBio's The Big Pitch. She has been selected for several fellowships, including the MassNextGen Fellowship for women-led early-stage life science businesses, The Capital Network Female Founder Fellowship, and the Henri Termeer Legacy Program. An advocate for DEI in both biotech and global health communities, Dr. Yen strives to center the voices and the needs of the most marginalized.

 

Anna Jacobs

Biologist
BARDA

Anna Jacobs

Biologist
BARDA

Anna Jacobs

Biologist
BARDA
 

Mayukh Das

Chief Operations Officer
Phiogen

Mayukh Das

Chief Operations Officer
Phiogen

Mayukh Das

Chief Operations Officer
Phiogen
 

Dylan Lawrence

Senior Scientist
Pfizer

Dylan Lawrence

Senior Scientist
Pfizer

Dylan Lawrence

Senior Scientist
Pfizer
 

Ashley Trama

Associate Vice President, Research and Development Program Management
Locus Biosciences

Ashley Trama

Associate Vice President, Research and Development Program Management
Locus Biosciences

Ashley Trama

Associate Vice President, Research and Development Program Management
Locus Biosciences
 

Matthew Dunne

Chief Scientific Officer
Micreos

Matthew Dunne

Chief Scientific Officer
Micreos

Matthew Dunne

Chief Scientific Officer
Micreos
 

Huiying Ren

Chief Scientist & Co-founder
Qingdao NABT Phagepharm

Huiying Ren

Chief Scientist & Co-founder
Qingdao NABT Phagepharm

Huiying Ren

Chief Scientist & Co-founder
Qingdao NABT Phagepharm
 

Aristobulo Loaiza

CEO
Hedros Bio

Aristobulo Loaiza

CEO
Hedros Bio

Aristobulo Loaiza

CEO
Hedros Bio
 

Matthew Tebeau

Chief Operating Officer
Phagelux

Matthew Tebeau

Chief Operating Officer
Phagelux

Matthew Tebeau

Chief Operating Officer
Phagelux
 

Amanda Bukardt

Chief Executive Officer
Phiogen

Amanda Bukardt

Chief Executive Officer
Phiogen

Amanda Bukardt

Chief Executive Officer
Phiogen
 

Danielle Peters

Research Officer
National Research Council Canada

Danielle Peters

Research Officer
National Research Council Canada

Danielle Peters

Research Officer
National Research Council Canada
 

Joseph Campbell

Program Officer
ex-NIH

Joseph Campbell

Program Officer
ex-NIH

Joseph Campbell

Program Officer
ex-NIH
 

Laura Kovanda

Executive Director
Astellas

Laura Kovanda

Executive Director
Astellas

Laura Kovanda

Executive Director
Astellas
 

Chrysi Sergaki

Microbiome Group Leader
MHRA

Chrysi Sergaki

Microbiome Group Leader
MHRA

Chrysi Sergaki

Microbiome Group Leader
MHRA

THE PHAGE FUTURES COMMUNITY

35%
Biotechs & Phage Producers
20%
Academic & Investors
15%
Pharma
15%
Service Providers
5%
Multinationals

DON'T JUST TAKE OUR WORD FOR IT

POSTER SUBMISSIONS

Are you looking to showcase your recent work to the phage community?

Our dedicated poster session is the perfect way to get your research noticed, ideal for PhD students or Post-Doctoral researchers. In order to present a poster, you need to register as a delegate. 

Please note that there is limited space available, and poster space is assigned on a first-come, first-served basis (subject to checks and successful registration). At the event, your presentation will be displayed in a dedicated poster area. The poster presentation session time of taking place is to be confirmed.

Posters should be sized A0 (841mm x 1189mm)

Poster abstract submission has now closed.

If you have any questions please contact [email protected]

Our Partners

Platinum Sponsor

GMP Sponsor

Event Partner

Venue Description

Venue

Aloft Boston Seaport District Hotel, 401-403 D Street, Boston, Massachusetts, 02210

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Download the Agenda

DOWNLOAD AGENDA

Contact Us

Conference Packages

REGISTRATION ENDS ON

  • Saturday, October 19, 2024 to Thursday, November 21, 2024
    Tier 1*
    $599
    Academics & Investors
  • Saturday, October 19, 2024 to Thursday, November 21, 2024
    Tier 2*
    $999
    Biotechs & Pharma
  • Saturday, October 19, 2024 to Thursday, November 21, 2024
    Tier 3*
    $1,499
    Start Up Solution Providers
  • Saturday, October 19, 2024 to Thursday, November 21, 2024
    Tier 4*
    $1,999
    Solution Providers
Preparing registration...

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.